On Wednesday, Nova received a positive adjustment to its Relative Strength (RS) Rating, from 65 to 74.
Can You Really Time The Stock Market?
IBD's unique RS Rating tracks market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating as they begin their biggest price moves. See if Nova can continue to show renewed price strength and clear that threshold.
Nova is not currently offering a proper buying opportunity. See if the stock goes on to build a base that could ignite a new run.
Regarding fundamentals, the company has posted rising EPS growth over the last two quarters. Sales growth has also increased over the same time frame.
The company holds the No. 2 rank among its peers in the Electronics-Semiconductor Equipment industry group. KLA is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
